Abstract
Topical corticosteroids are the mainstay of treatment for atopic dermatitis (AD) and when used as directed, are highly effective. Upwards of 50% to 88% of children and adolescents are non-adherent with their prescribed regimen. In addition, inaccurate dosing of topical steroids is a large source of treatment failure. Existing studies exploring the barriers and interventions in adherence place the blame and responsibility on patients and clinicians to improve outcomes. Little is known about topical drug delivery devices as a source of non-adherence, specifically issues concerning inaccurate dosing.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
